133 related articles for article (PubMed ID: 27860280)
1. Design, synthesis, and biological evaluation of chrysin derivatives as potential FabH inhibitors.
Li HX; Wang ZC; Qian YM; Yan XQ; Lu YD; Zhu HL
Chem Biol Drug Des; 2017 Jan; 89(1):136-140. PubMed ID: 27860280
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
Zhang F; Wen Q; Wang SF; Shahla Karim B; Yang YS; Liu JJ; Zhang WM; Zhu HL
Bioorg Med Chem Lett; 2014 Jan; 24(1):90-5. PubMed ID: 24332628
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
Wang XL; Zhang YB; Tang JF; Yang YS; Chen RQ; Zhang F; Zhu HL
Eur J Med Chem; 2012 Nov; 57():373-82. PubMed ID: 23124163
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of 2-styryl of 5-Nitroimidazole derivatives and antimicrobial activities as FabH inhibitors.
Duan YT; Wang ZC; Sang YL; Tao XX; Teraiya SB; Wang PF; Wen Q; Zhou XJ; Ding L; Yang YH; Zhu HL
Eur J Med Chem; 2014 Apr; 76():387-96. PubMed ID: 24594526
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors.
Qin YJ; Wang PF; Makawana JA; Wang ZC; Wang ZN; Yan-Gu ; Jiang AQ; Zhu HL
Bioorg Med Chem Lett; 2014 Nov; 24(22):5279-83. PubMed ID: 25587588
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and antimicrobial activities evaluation of Schiff base derived from secnidazole derivatives as potential FabH inhibitors.
Li Y; Zhao CP; Ma HP; Zhao MY; Xue YR; Wang XM; Zhu HL
Bioorg Med Chem; 2013 Jun; 21(11):3120-6. PubMed ID: 23602519
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity.
Li JR; Li DD; Wang RR; Sun J; Dong JJ; Du QR; Fang F; Zhang WM; Zhu HL
Eur J Med Chem; 2014 Mar; 75():438-47. PubMed ID: 24561667
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and molecular docking of 1,4-benzodioxane thiazolidinedione piperazine derivatives as FabH inhibitors.
Sun J; He W; Liu HY; Qin J; Ye CL
Bioorg Chem; 2019 Jul; 88():102958. PubMed ID: 31054434
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel bacterial FabH inhibitors (Pyrazol-Benzimidazole amide derivatives): Design, synthesis, bioassay, molecular docking and crystal structure determination.
Wang YT; Shi TQ; Fu J; Zhu HL
Eur J Med Chem; 2019 Jun; 171():209-220. PubMed ID: 30925337
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and antimicrobial activities of nitroimidazole derivatives containing 1,3,4-oxadiazole scaffold as FabH inhibitors.
Li Y; Luo Y; Hu Y; Zhu DD; Zhang S; Liu ZJ; Gong HB; Zhu HL
Bioorg Med Chem; 2012 Jul; 20(14):4316-22. PubMed ID: 22710102
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antimicrobial activities of oximes derived from O-benzylhydroxylamine as FabH inhibitors.
Luo Y; Zhang LR; Hu Y; Zhang S; Fu J; Wang XM; Zhu HL
ChemMedChem; 2012 Sep; 7(9):1587-93. PubMed ID: 22811397
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics.
Li HQ; Shi L; Li QS; Liu PG; Luo Y; Zhao J; Zhu HL
Bioorg Med Chem; 2009 Sep; 17(17):6264-9. PubMed ID: 19664929
[TBL] [Abstract][Full Text] [Related]
13. Design of Arylsulfonylhydrazones as Potential FabH Inhibitors: Synthesis, Antimicrobial Evaluation and Molecular Docking.
Fernandes TB; Segretti ND; Lourenço FR; Cândido TM; Baby AR; Barbosa EG; Parise-Filho R
Med Chem; 2021; 17(5):474-484. PubMed ID: 31763975
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel oxoindolin derivatives as atypical dual inhibitors for DNA Gyrase and FabH.
Yang YS; Su MM; Xu JF; Liu QX; Bai LF; Hu XW; Zhu HL
Bioorg Chem; 2019 Dec; 93():103309. PubMed ID: 31585266
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2/4-benzaldehyde-amino) phenyl-N'-phenyl-thiourea.
Zhang HJ; Qin X; Liu K; Zhu DD; Wang XM; Zhu HL
Bioorg Med Chem; 2011 Sep; 19(18):5708-15. PubMed ID: 21872479
[TBL] [Abstract][Full Text] [Related]
16. New antibacterial agents: Hybrid bioisoster derivatives as potential E. coli FabH inhibitors.
Segretti ND; Serafim RA; Segretti MC; Miyata M; Coelho FR; Augusto O; Ferreira EI
Bioorg Med Chem Lett; 2016 Aug; 26(16):3988-93. PubMed ID: 27426865
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, molecular modeling and biological evaluation of β-ketoacyl-acyl carrier protein synthase III (FabH) as novel antibacterial agents.
Zhang HJ; Zhu DD; Li ZL; Sun J; Zhu HL
Bioorg Med Chem; 2011 Aug; 19(15):4513-9. PubMed ID: 21741250
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, molecular docking and biological evaluation of metronidazole derivatives containing piperazine skeleton as potential antibacterial agents.
Wang SF; Yin Y; Qiao F; Wu X; Sha S; Zhang L; Zhu HL
Bioorg Med Chem; 2014 Apr; 22(8):2409-15. PubMed ID: 24680059
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents.
Shi L; Fang RQ; Zhu ZW; Yang Y; Cheng K; Zhong WQ; Zhu HL
Eur J Med Chem; 2010 Sep; 45(9):4358-64. PubMed ID: 20557983
[TBL] [Abstract][Full Text] [Related]
20. Identification of a new binding site in E. coli FabH using Molecular dynamics simulations: validation by computational alanine mutagenesis and docking studies.
Ramamoorthy D; Turos E; Guida WC
J Chem Inf Model; 2013 May; 53(5):1138-56. PubMed ID: 23581389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
